KELLY RALPH DAVID 4

What Happened

• Kelly Ralph David, a director of Acadia Healthcare Company, Inc. (ACHC), received an award of 6,331 shares on May 6, 2026. The Form 4 reports an acquisition price of $0.00 (i.e., a grant/award rather than an open-market purchase or cash exercise). The filing notes these shares will vest in equal annual installments over three years beginning May 6, 2027.

Key Details

• Transaction date: May 6, 2026; Form 4 filed May 8, 2026 (timely filing).
• Reported price: $0.00 per share (award/grant).
• Shares acquired: 6,331.
• Vesting: Footnote F1 — vestes over 3 years in equal yearly installments starting May 6, 2027.
• Shares owned after transaction: not specified in the provided filing details.
• Transaction code: A (award/grant).

Context

• This was a compensation grant (likely restricted stock or RSUs) to a director, not an open-market purchase or sale — such awards are common for board compensation and typically vest over time.
• Grants do not necessarily signal immediate buying or selling intent; they create potential future ownership as vesting conditions are met and may dilute outstanding shares over time.